BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12921294)

  • 21. [Updated treatment of achondroplasia].
    Seino Y
    Clin Calcium; 2009 Mar; 19(3):432-6. PubMed ID: 19252254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
    Shiang R; Thompson LM; Zhu YZ; Church DM; Fielder TJ; Bocian M; Winokur ST; Wasmuth JJ
    Cell; 1994 Jul; 78(2):335-42. PubMed ID: 7913883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple and rapid quantitative method of detection of the common achondroplasia mutation: analysis in mismatch repair deficient cells.
    Grewal RP
    Genetika; 2005 Aug; 41(8):1137-41. PubMed ID: 16161636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.
    Henderson JE; Naski MC; Aarts MM; Wang D; Cheng L; Goltzman D; Ornitz DM
    J Bone Miner Res; 2000 Jan; 15(1):155-65. PubMed ID: 10646125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM; Losekoot M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia.
    Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
    Horm Res; 1996; 45(1-2):108-10. PubMed ID: 8742128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
    Grigelioniené G; Hagenäs L; Eklöf O; Neumeyer L; Haereid PE; Anvret M
    Hum Mutat; 1998; 11(4):333. PubMed ID: 10215410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of fibroblast growth factor receptor 3 gene mutation at nucleotide 1138 site in congenita achondroplasia patients].
    Ni J; Lu G; Wang W; Chen F; Qin H; Wang D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):205-8. PubMed ID: 12048679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
    Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
    Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
    Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
    South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data.
    Tsai FJ; Tsai CH; Chang JG; Wu JY
    Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885
    [No Abstract]   [Full Text] [Related]  

  • 32. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
    Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
    Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gly374Arg mutation in Fgfr3 causes achondroplasia in mice].
    Wang JM; Du XL; Li CL; Yin LJ; Chen B; Sun J; Su N; Zhao L; Song RH; Song WW; Chen L; Deng CX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):537-41. PubMed ID: 15583977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An uncommon G375C substitution in a newborn with achondroplasia.
    Addor MC; Gudinchet F; Truttmann A; Schorderet DF
    Genet Couns; 2000; 11(2):169-74. PubMed ID: 10893668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achondroplasia with the FGFR3 1138g-->a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father.
    Sobetzko D; Braga S; Rüdeberg A; Superti-Furga A
    J Med Genet; 2000 Dec; 37(12):958-9. PubMed ID: 11186940
    [No Abstract]   [Full Text] [Related]  

  • 37. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
    Hung CC; Lee CN; Chang CH; Jong YJ; Chen CP; Hsieh WS; Su YN; Lin WL
    Clin Biochem; 2008 Feb; 41(3):162-6. PubMed ID: 18199430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.
    Yamanaka Y; Tanaka H; Koike M; Nishimura R; Seino Y
    J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
    Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
    Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
    Adar R; Monsonego-Ornan E; David P; Yayon A
    J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.